Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image

U.S. to Invest $200 Million to Shorten Organ Transplant Wait Lists

By Conor Bryant

The U.S. government, led by the Department of Defense, announced plans on Monday to invest $200 million to help shorten the waiting list for organ transplants.

It is designed to support technologies aimed at repairing and replacing cells and tissues, says Jeff Zients, director of the White House National Economic Council. $160 million in public-private investment will go to a new Advanced Tissue Biofabrication Manufacturing Innovation Institute to aid in developing next-generation manufacturing techniques for cell therapies. Another $7 million will go towards awards for small businesses working to advance the science of tissue preservation.

Over 120,000 people in the U.S. are on a donor waiting list, with 80% of those waiting for a kidney. The number of organ transplants last year was around 30,000, the most annual transplants ever. End stage kidney failure cost Medicare $34 billion a year, more than 7% of the total budget.

The incoming president of the American Society of Transplant Surgeons, Dr. Timothy Pruett, says cutting wait times for organ transplants is a multi-faceted challenge, and while the efforts from the White House are a great start, sustained additional efforts are required.

The sharing of information regarding donors has also seen an increase in attention. Walter Reed National Military Center announced a pilot to help patients find hard to match kidneys; and more than 30 transplant centers said they would share data for hard to match kidney patients. Facebook, Tinder and Twitter are also developing new tools to increase donor registration options.

To read the full article click here.

https://globalbioethics.org/wp-content/uploads/2016/06/Robotic-Surgery-Just-Got-More-Autonomous.mp4

Other Posts

Prof Cheah Phaik YeongAna Lita2022-11-07T18:55:06+00:00

Ana Lita2022-11-07T18:55:06+00:00November 7th, 2022|Comments Off on Prof Cheah Phaik Yeong

2022 “Bioethics, Wars and Pandemics” TestimonialsAna Lita2022-08-11T02:32:40+00:00

Ana Lita2022-08-11T02:32:40+00:00July 26th, 2022|Comments Off on 2022 “Bioethics, Wars and Pandemics” Testimonials

Bioethics in the Second Cold War by Jonathan D Moreno PhDAna Lita2022-06-07T15:42:38+00:00

Ana Lita2022-06-07T15:42:38+00:00June 7th, 2022|Comments Off on Bioethics in the Second Cold War by Jonathan D Moreno PhD

Call for Applications: “Bioethics, Wars and Pandemics” Summer School Online (July 18 – 23) 2022Ana Lita2022-06-07T14:33:04+00:00

Ana Lita2022-06-07T14:33:04+00:00June 7th, 2022|Comments Off on Call for Applications: “Bioethics, Wars and Pandemics” Summer School Online (July 18 – 23) 2022

By Admin@gbi|2020-04-09T23:46:59+00:00June 15th, 2016|News-Articles|1 Comment

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Gallery

    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024

  • AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    Gallery

    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics

  • A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    Gallery

    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD

  • Jonathan D. Moreno Ph.D. Keynote Speaker
    Jonathan D. Moreno Ph.D. Keynote Speaker
    Gallery

    Jonathan D. Moreno Ph.D. Keynote Speaker

  • Jeanne F. Loring Ph.D. Keynote Speaker
    Jeanne F. Loring Ph.D. Keynote Speaker
    Gallery

    Jeanne F. Loring Ph.D. Keynote Speaker

One Comment

  1. Avatar
    Dan Walter July 6, 2016 at 1:08 pm - Reply

    The US transplant program is ethically challenged. The entire campaign for living kidney donation is based on false premises: https://www.beaconreader.com/dan-walter/why-the-campaign-for-living-kidney-donation-is-bullshit

Leave A Comment Cancel reply

Recent Tweets

Tweets by GBISummerSchool

Find us on Facebook

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area